dehydroepiandrosterone

The medicine is intended for the treatment of dehydroepiandrosterone (DHEA) deficiency in women and men, where such deficiency has been confirmed by laboratory tests.

Form: tablets

ATC: A14AA07

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is intended for the treatment of dehydroepiandrosterone (DHEA) deficiency in women and men, where such deficiency has been confirmed by laboratory tests.

Form: tablets

ATC: A14AA07

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is used to supplement DHEA hormone deficiencies in women and men where such deficiency has been confirmed by laboratory tests. It may also have a beneficial effect on certain symptoms related to the aging of the body.

Form: tablets, film-coated

ATC: A14AA07

Manufacturer: Aflofarm Farmacja Polska Limited

It is used in the treatment of laboratory-confirmed dehydroepiandrosterone (DHEA) deficiency in women and men. It may also be used as a supportive treatment in cases of menopause, andropause, decline in physical and mental performance, mood changes, decreased sexual activity, or immunity problems.

Form: tablets

ATC: A14AA07

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicinal product is intended for the treatment of dehydroepiandrosterone deficiency in women, where this deficiency has been confirmed by laboratory tests. It may also be used as a supportive treatment in cases of menopause, decline in physical and mental performance, mood deterioration, decreased sexual activity, or immunity problems.

Form: tablets

ATC: A14AA07

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

It is used in men to treat dehydroepiandrosterone (DHEA) deficiency, which has been confirmed by laboratory tests.

Form: tablets

ATC: A14AA07

Manufacturer: Aflofarm Farmacja Polska Limited